Jayraz Luchoomun

990 total citations
17 papers, 764 citations indexed

About

Jayraz Luchoomun is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jayraz Luchoomun has authored 17 papers receiving a total of 764 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Molecular Biology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jayraz Luchoomun's work include Lipoproteins and Cardiovascular Health (5 papers), Cholesterol and Lipid Metabolism (5 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers). Jayraz Luchoomun is often cited by papers focused on Lipoproteins and Cardiovascular Health (5 papers), Cholesterol and Lipid Metabolism (5 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers). Jayraz Luchoomun collaborates with scholars based in United States, France and Belgium. Jayraz Luchoomun's co-authors include M. Mahmood Hussain, Ahmed Bakillah, Scott Turner, Marc K. Hellerstein, Charles Kunsch, M. Mahmood Hussain, Dmitri Sviridov, Alan T. Remaley, Denis Sviridov and John A. Stonik and has published in prestigious journals such as Journal of Biological Chemistry, Arteriosclerosis Thrombosis and Vascular Biology and Journal of Lipid Research.

In The Last Decade

Jayraz Luchoomun

17 papers receiving 749 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jayraz Luchoomun United States 13 346 280 205 132 119 17 764
Emi Yakushiji Japan 16 381 1.1× 289 1.0× 193 0.9× 184 1.4× 110 0.9× 26 814
M R McCall United States 14 414 1.2× 256 0.9× 310 1.5× 120 0.9× 83 0.7× 16 715
Jeffery T. Billheimer United States 7 448 1.3× 224 0.8× 297 1.4× 144 1.1× 121 1.0× 8 818
C. Justin Cooke United Kingdom 10 476 1.4× 199 0.7× 386 1.9× 124 0.9× 114 1.0× 12 906
Shunichi Takiguchi Japan 17 383 1.1× 272 1.0× 190 0.9× 166 1.3× 162 1.4× 32 854
R W Brocia United States 9 397 1.1× 299 1.1× 333 1.6× 169 1.3× 205 1.7× 9 861
Daoguang Yan China 11 252 0.7× 456 1.6× 146 0.7× 120 0.9× 120 1.0× 13 898
Patrick M. Hutchins United States 16 401 1.2× 312 1.1× 333 1.6× 143 1.1× 137 1.2× 19 915
Christine K. Castle United States 16 482 1.4× 375 1.3× 311 1.5× 145 1.1× 73 0.6× 24 899
Sandhya Sankaranarayanan United States 10 323 0.9× 164 0.6× 186 0.9× 122 0.9× 67 0.6× 15 626

Countries citing papers authored by Jayraz Luchoomun

Since Specialization
Citations

This map shows the geographic impact of Jayraz Luchoomun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jayraz Luchoomun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jayraz Luchoomun more than expected).

Fields of papers citing papers by Jayraz Luchoomun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jayraz Luchoomun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jayraz Luchoomun. The network helps show where Jayraz Luchoomun may publish in the future.

Co-authorship network of co-authors of Jayraz Luchoomun

This figure shows the co-authorship network connecting the top 25 collaborators of Jayraz Luchoomun. A scholar is included among the top collaborators of Jayraz Luchoomun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jayraz Luchoomun. Jayraz Luchoomun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Holleboom, Adriaan G., Lily Jakulj, Remco Franssen, et al.. (2013). In vivo tissue cholesterol efflux is reduced in carriers of a mutation in APOA1. Journal of Lipid Research. 54(7). 1964–1971. 20 indexed citations
2.
Davidson, Michael H., Jayraz Luchoomun, Salena Killion, et al.. (2013). Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans. Atherosclerosis. 230(2). 322–329. 40 indexed citations
3.
Christoffersen, Christina, et al.. (2013). Apolipoprotein M promotes mobilization of cellular cholesterol in vivo. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1831(7). 1287–1292. 33 indexed citations
4.
Turner, Scott, Michael H. Davidson, Salena Killion, et al.. (2012). Measurement of Reverse Cholesterol Transport Pathways in Humans: In Vivo Rates of Free Cholesterol Efflux, Esterification, and Excretion. Journal of the American Heart Association. 1(4). e001826–e001826. 56 indexed citations
5.
Amar, Marcelo, Wilissa D’Souza, Scott Turner, et al.. (2010). 5A Apolipoprotein Mimetic Peptide Promotes Cholesterol Efflux and Reduces Atherosclerosis in Mice. Journal of Pharmacology and Experimental Therapeutics. 334(2). 634–641. 89 indexed citations
6.
Luyendyk, James P., Michael Tencati, Todd Holscher, et al.. (2007). A Novel Class of Antioxidants Inhibit LPS Induction of Tissue Factor by Selective Inhibition of the Activation of ASK1 and MAP Kinases. Arteriosclerosis Thrombosis and Vascular Biology. 27(8). 1857–1863. 36 indexed citations
8.
Clermont, Allen C., Junichi Takahashi, Cynthia L. Sundell, et al.. (2004). Early Diabetes–induced Retinal Vascular Abnormalities Are Ameliorated By The Antioxidant Agix–4207 In Diabetic Rats. Investigative Ophthalmology & Visual Science. 45(13). 3207–3207. 1 indexed citations
9.
Kunsch, Charles, Jayraz Luchoomun, Richard F. Arrendale, et al.. (2004). Selective Inhibition of Endothelial and Monocyte Redox-Sensitive Genes by AGI-1067: A Novel Antioxidant and Anti-Inflammatory Agent. Journal of Pharmacology and Experimental Therapeutics. 308(3). 820–829. 53 indexed citations
10.
Murata, Seiichiro, Cynthia L. Sundell, M.A. Lijkwan, et al.. (2004). EFFECTS OF AGI-1096, A NOVEL ANTIOXIDANT COMPOUND WITH ANTI-INFLAMMATORY AND ANTIPROLIFERATIVE PROPERTIES, ON RODENT ALLOGRAFT ARTERIOSCLEROSIS. Transplantation. 77(10). 1494–1500. 6 indexed citations
11.
Luchoomun, Jayraz & M. Mahmood Hussain. (1999). Assembly and Secretion of Chylomicrons by Differentiated Caco-2 Cells. Journal of Biological Chemistry. 274(28). 19565–19572. 145 indexed citations
12.
Luchoomun, Jayraz, et al.. (1998). Lysophosphatidylcholine increases apolipoprotein B secretion by enhancing lipid synthesis and decreasing its intracellular degradation in HepG2 cells. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1391(1). 13–24. 15 indexed citations
13.
Nion, Stéphane, Jayraz Luchoomun, Berlinda Vanloo, et al.. (1998). Branched synthetic peptide constructs mimic cellular binding and efflux of apolipoprotein AI in reconstituted high density lipoproteins. Atherosclerosis. 141(2). 227–235. 2 indexed citations
14.
Luchoomun, Jayraz, et al.. (1997). Assembly and Secretion of VLDL in Nondifferentiated Caco-2 Cells Stably Transfected With Human Recombinant ApoB48 cDNA. Arteriosclerosis Thrombosis and Vascular Biology. 17(11). 2955–2963. 32 indexed citations
15.
Bakillah, Ahmed, et al.. (1997). Measurement of apolipoprotein B in various cell lines: Correlation between intracellular levels and rates of secretion. Lipids. 32(10). 1113–1118. 46 indexed citations
16.
Hussain, M. Mahmood, et al.. (1996). Chylomicron assembly and catabolism: role of apolipoproteins and receptors. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1300(3). 151–170. 144 indexed citations
17.
Luchoomun, Jayraz, Nathalie Théret, Véronique Clavey, et al.. (1994). Structural domain of apolipoprotein A-I involved in its interaction with cells. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1212(3). 319–326. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026